CVE-2024-6369
Published: 27 June 2024
Summary
CVE-2024-6369 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Labvantage Laboratory Information Management System. Its CVSS base score is 5.3 (Medium).
Operationally, ranked at the 31.9th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-47476
Vulnerability details
A vulnerability classified as problematic has been found in LabVantage LIMS 2017. Affected is an unknown function of the file /labvantage/rc?command=page&sdcid=LV_ReagentLot of the component POST Request Handler. The manipulation of the argument mode leads to cross site scripting. It is…
more
possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. VDB-269802 is the identifier assigned to this vulnerability.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.